Literature DB >> 27477697

Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signalling.

S Bernaudo, M Salem, X Qi, W Zhou, C Zhang, W Yang, D Rosman, Z Deng, G Ye, B B Yang, B Vanderhyden, Z Wu, C Peng.   

Abstract

Entities:  

Year:  2016        PMID： 27477697      PMCID： PMC5024151          DOI： 10.1038/onc.2016.65

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
Correction to: Oncogene advance online publication, 15 February 2016; doi:10.1038/onc.2016.15 Following the online publication of this article, the authors noticed an error in the presentation of one of the authors’ names. ‘B Yang’ has now been corrected to ‘BB Yang’. The authors apologise for any inconvenience caused by this error.
  4 in total

1.  N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma.

Authors:  Binbin Chen; Wei Jiang; Ying Huang; Jian Zhang; Peng Yu; Lirong Wu; Hao Peng
Journal:  Oncogene       Date:  2022-02-26       Impact factor: 9.867

2.  Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells.

Authors:  Stefanie Bernaudo; Shahin Khazai; Eilyad Honarparvar; Alina Kopteva; Chun Peng
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

3.  Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling.

Authors:  Chenyang Zhao; Jinlan Gao; Sen Li; Qi Liu; Xiaoyu Hou; Shenghuan Liu; Xuesha Xing; Manni Sun; Shusen Wang; Yang Luo
Journal:  Biomed Res Int       Date:  2018-10-21       Impact factor: 3.411

Review 4.  MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies.

Authors:  Hyun Ah Seo; Sokviseth Moeng; Seokmin Sim; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.